Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT
Ana Cerezo1,
Holger Kalthoff2,
Markus Schuermann3,
Birgit Schäfer4 and
Petra Boukamp1,*
1 Deutsches Krebsforschungszentrum, Division of Skin Carcinogenesis, Im
Neuenheimer Feld 280, D-69120 Heidelberg, Germany
2 Klinik für Allg. Chirurgie und Thoraxchirurgie, Molecular Oncology,
University of Kiel, D-24105 Kiel, Germany
3 University of Marburg, Department of Haematology and Oncology, Baldinger Str.
D-35033 Marburg, Germany
4 University of Heidelberg, Department of Immunology, Im Neuenheimer Feld 305,
D-69120 Heidelberg, Germany

View larger version (59K):
[in a new window]
|
Fig. 1. Effect of TGF-ß1 signaling on proliferation and telomerase activity in
either untransfected HaCaT cells (a), hTERT- (HaCaT-TERT) (b) or c-Myc
(HaCaT-myc) transfectants (c). Upper panels: Western blot showing
phosphorylation of Smad2 and expression of c-Myc after TGF-ß1 treatment.
Middle panels: BrdU incorporation assay. Untreated cells are taken as 100%.
Lower panel: TGF-ß1 downregulation of telomerase activity in HaCaT and
HaCaT-myc cells and telomerase maintenance in HaCaT-TERT cells. Telomerase
activity was measured by conventional TRAP assay. From each sample an
RNase-inactivated negative control was assayed in parallel. IC, internal
control.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
© The Company of Biologists Ltd 2002